Apremilast

Details

Files
Generic Name:
Apremilast
Project Status:
Complete
Therapeutic Area:
Psoriasis, moderate to severe plaque
Manufacturer:
Celgene
Call for patient/clinician input open:
Brand Name:
Otezla
Project Line:
Reimbursement Review
Project Number:
SR0478-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Performance Metric:
Achieved
Submission Type:
Resubmission
Indications:
Psoriasis, moderate to severe plaque
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation: